share_log

诺辉健康(06606.HK)：预计2023年度收入总额同比增长158.9%至168.2%

Novartis Health (06606.HK): Total revenue is expected to increase by 158.9% to 168.2% year-on-year in 2023

Gelonghui Finance ·  Jan 22 03:54

On January 22, GLONGHUI Health (06606.HK) announced that the Group's total revenue for the year ended December 31, 2023 is expected to be between RMB 1,9788 million and RMB 2,0498 million, an increase of 158.9% to 168.2% from approximately RMB 764.4 million for the year ended December 31, 2022. The Group's gross profit forecast for the year ended 31 December 2023 will range from RMB1,807.6 million to RMB1,873.2 million, an increase of 179.9% to 190.0% over approximately RMB645.9 million for the year ended 31 December 2022. The increase in total revenue and gross profit is mainly due to the increase in revenue and gross profit of the Group's products (i.e. Chang Wei Qing, Youyou Tube and Pu Pu Tube).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment